Skip to main content

Advertisement

Log in

Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance

  • Pancreas
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate pancreatic T1 mapping and extracellular volume (ECV) fraction’s feasibility to assess impaired glucose tolerance (IGT) patients.

Methods

A total of 45 consecutive patients with known or suspected pancreatic disease underwent contrast-enhanced magnetic resonance (MR) imaging, including T1 mapping, using saturation recovery sequence. Patients were classified into three groups based on the American Diabetes Association criteria: no-diabetes subjects, HbA1c < 5.7%; pre-diabetes, 5.7% ≤ HbA1c < 6.5%; and type 2 diabetes mellitus (T2DM), HbA1c ≥ 6.5%. Pre-contrast pancreatic T1 value and ECV of the pancreas were computed, and then pre-contrast pancreatic T1 value, ECV and HbA1c values were compared. The present prospective study was approved by our institutional review board. Written informed consent was obtained from all patients.

Results

A positive correlation between HbA1c values and both pre-contrast pancreatic T1 value and ECV (r = 0.79, P < 0.001 and r = 0.60, P < 0.001, respectively) were observed. The pre-contrast pancreatic T1 value and ECV were significantly higher in T2DM vs. no-diabetes subjects and pre-diabetes (P < 0.001). No significant difference between two qualitative values (P = 0.14) was found, however, the sensitivity, specificity, and area under the receiver-operating-characteristic curve differentiating no-diabetes subjects and pre-diabetes from T2DM were superior in ECV (100%, 93.5%, and 0.990) vs. pre-contrast pancreatic T1 values (84.6%, 96.8%, and 0.906).

Conclusions

The ECV of the pancreas could serve as a potential imaging biomarker for the assessment of pancreatic fibrosis leading to IGT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9:151-159Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9:151-159

    CAS  PubMed  Google Scholar 

  2. Noda Y, Goshima S, Tanaka K, et al. Findings in pancreatic MRI associated with pancreatic fibrosis and HbA1c values. J Magn Reson Imaging 2016; 43:680-687

    Article  Google Scholar 

  3. Fitts M, Breton E, Kholmovski EG, et al. Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence. Magn Reson Med 2013; 70:1274-1282

    Article  Google Scholar 

  4. Tirkes T, Lin C, Fogel EL, Sherman SS, Wang Q, Sandrasegaran K. T1 mapping for diagnosis of mild chronic pancreatitis. J Magn Reson Imaging 2017; 45:1171-1176

    Article  Google Scholar 

  5. Noda Y, Goshima S, Tsuji Y, et al. Correlation of quantitative pancreatic T1 value and HbA1c value in subjects with normal and impaired glucose tolerance. J Magn Reson Imaging 2019; 49:711-718

    Article  Google Scholar 

  6. Luetkens JA, Homsi R, Sprinkart AM, et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 2016; 17:154-161

    Article  Google Scholar 

  7. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010; 122:138-144

    Article  Google Scholar 

  8. Luetkens JA, Klein S, Traber F, et al. Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology 2018; 288:748-754

    Article  Google Scholar 

  9. American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41:S13-S27

  10. Morita K, Oda S, Utsunomiya D, et al. Saturation Recovery Myocardial T1 Mapping with a Composite Radiofrequency Pulse on a 3T MR Imaging System. Magn Reson Med Sci 2018; 17:35-41

    Article  CAS  Google Scholar 

  11. Kim PK, Hong YJ, Im DJ, et al. Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol 2017; 18:113-131

    Article  Google Scholar 

  12. Kise Y, Chikui T, Yamashita Y, Kobayashi K, Yoshiura K. Clinical usefulness of the mDIXON Quant the method for estimation of the salivary gland fat fraction: comparison with MR spectroscopy. Br J Radiol 2017; 90:20160704

    Article  Google Scholar 

  13. Schelbert EB, Messroghli DR. State of the Art: Clinical Applications of Cardiac T1 Mapping. Radiology 2016; 278:658-676

    Article  Google Scholar 

  14. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843

    Article  CAS  Google Scholar 

  15. Cui Y, Cao Y, Song J, et al. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation. J Cardiovasc Magn Reson 2018; 20:25

    Article  Google Scholar 

  16. Xin A, Mizukami H, Inaba W, Yoshida T, Takeuchi YK, Yagihashi S. Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes. J Clin Endocrinol Metab 2017; 102:3162-3171

    Article  Google Scholar 

  17. Winston CB, Mitchell DG, Outwater EK, Ehrlich SM. Pancreatic signal intensity on T1-weighted fat saturation MR images: clinical correlation. J Magn Reson Imaging 1995; 5:267-271

    Article  CAS  Google Scholar 

  18. Rathmann W, Haastert B, Oscarsson J, Berglind N, Wareham NJ. Inverse association of HbA1c with faecal elastase 1 in people without diabetes. Pancreatology 2015; 15:620-625

    Article  CAS  Google Scholar 

  19. Loser C, Mollgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996; 39:580-586

    Article  CAS  Google Scholar 

  20. Fukukura Y, Kumagae Y, Higashi R, et al. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma. Pancreas 2019; 48:1360-1366

    Article  Google Scholar 

  21. Tirkes T, Mitchell JR, Li L, Zhao X, Lin C. Normal T1 relaxometry and extracellular volume of the pancreas in subjects with no pancreas disease: correlation with age and gender. Abdom Radiol (NY) 2019; 44:3133-3138

    Article  Google Scholar 

  22. International Expert C. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32:1327-1334

    Article  Google Scholar 

  23. Dorcely B, Katz K, Jagannathan R, et al. Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes Metab Syndr Obes 2017; 10:345-361

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshifumi Noda.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest to disclose.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This prospective study was approved by our Institutional Review Board, and a written informed consent was obtained from all patients.

Informed consent

The requirement for informed consent was obtained from all patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noda, Y., Goshima, S., Tsuji, Y. et al. Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance. Abdom Radiol 45, 449–456 (2020). https://doi.org/10.1007/s00261-019-02384-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-019-02384-7

Keywords

Navigation